Form 4: Director Kochi Chang Acquires YD Bio Shares via RSU Vest

Director Kochi Chang acquired 2,081 ordinary shares of YD Bio Ltd through the vesting of restricted share units on March 31, 2026.

Summary

• Director Kochi Chang reported the acquisition of 2,081 ordinary shares of YD Bio Ltd (YDES).
• The transaction occurred on March 31, 2026, via the vesting of restricted share units (RSUs).
• The RSUs were granted under the company's Equity Incentive Plan with an aggregate target grant date fair value of $60,000.
• The vesting schedule consists of four equal quarterly installments, with the first installment vesting on March 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Director alignment with shareholder interests through equity-based compensation.
• Transparent disclosure of executive compensation structure.

Negatives

• None identified; this is a routine equity compensation disclosure.

Risks

• Future vesting amounts are subject to the seven-day volume-weighted average price of the company's shares, introducing volatility in the number of shares issued.

Future Outlook

The director is scheduled to receive additional shares in three remaining quarterly installments, contingent on the company's share price performance.

Management Comments

• The RSUs vest in four equal quarterly installments beginning on March 31, 2026.

Industry Context

StockSavvy.ai notes that this filing represents standard corporate governance practice where directors receive equity-based compensation to align their incentives with long-term company performance.

Comparison to Industry Standards

• The use of quarterly vesting schedules for director equity is consistent with standard corporate governance practices in the biotechnology sector.
• The reliance on volume-weighted average pricing for share issuance is a common mechanism to mitigate short-term price manipulation.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity incentive plan execution.

Next Steps

• Remaining three quarterly vesting installments of the RSU grant.

Key Dates

Keywords

YD Bio, YDES, Form 4, Insider Trading, Equity Incentive Plan, Restricted Share Units, Director Compensation